Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03543046 · ClinicalTrials.gov registry record · NA
Tortle Midliner and Intraventricular Hemorrhage
A NA study, sponsored by Orlando Health.
- Terminated
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT03543046 is a NA study that was terminated before completion, run by Orlando Health. The registered enrollment target is 27 participants.
The verdict
NCT03543046, a NA study, was terminated before completion, sponsored by Orlando Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if early application of the Tortle Midliner for preterm infants, ≤ 3 hours following birth and with subsequent continuous use through 72 hrs. of life to ensure maintenance of optimal midline positioning (Tortle group), will impact the IVH outcome as determined by a reduction in the rate and/or severity of IVH when compared to infants receiving the standard regimen of care (Control group).
Interventions
- DEVICE Tortle Midliner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-08-24 |
| Est. Completion | 2020-01-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03543046
The ClinicalTrials.gov registry entry for NCT03543046 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Orlando Health, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tortle Midliner is the first listed.
NCT03543046 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03543046 about?
NCT03543046 is a clinical study titled "Tortle Midliner and Intraventricular Hemorrhage". The purpose of the study is to determine if early application of the Tortle Midliner for preterm infants, ≤ 3 hours following birth and with subsequent continuous use through 72 hrs. of life to ensure maintenance of optimal midline positioning (Tortle group), will impact the IVH outcome as determine...
What is the current status of trial NCT03543046?
This trial is currently terminated. It is a NA study. The enrollment target is 27 participants. The study started on 2018-08-24. Estimated completion is 2020-01-09.
What interventions are being tested in trial NCT03543046?
The interventions under investigation include: Tortle Midliner (DEVICE).
Who is sponsoring clinical trial NCT03543046?
This trial is sponsored by Orlando Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.